FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileThe Cigna Group
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CI
The Cigna Group Stock AnalysisComprehensive stock analysis for The Cigna Group (CI) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCI
CI
The Cigna Group
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CI
  1. Home
  2. Stocks
  3. The Cigna Group

The Cigna Group

🇺🇸CI•NYSE

The Cigna Group

🇺🇸CI•NYSE
Market cap
$79.09B
Sentiment

Your view on CI

Mkt Cap
$79.09B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About The Cigna Group

Industry
Medical - Healthcare Plans
Sector
Healthcare
CEO
David Michael Cordani
Headquarters
900 Cottage Grove Road, Bloomfield, CT, US
Industry
Medical - Healthcare Plans
Sector
Healthcare
CEO
David Michael Cordani
Headquarters
900 Cottage Grove Road, Bloomfield, CT, US
Description

The Cigna Group provides insurance and related products and services in the United States.

Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations.

The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations.

It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for The Cigna Group from FRC's valuation model, read against the market price. CI last traded at $300.16, 13.2× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for The Cigna Group. Starting points for The Cigna Group: P/E 13.2, EPS $22.79, beta 0.30 — an Medical - Healthcare Plans name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for The Cigna Group. The Cigna Group paid $6.19 per share over the last year — a 2.1% yield at the current $300.16 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for The Cigna Group. Trailing twelve-month EPS for The Cigna Group stands at $22.79. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$343.20

average of 15 firms, last 12 months

 

$343.20

Low $302.00

Median $340.00

High $400.00

 

Analyst Ratings

Buy16 firms, last 12 months
  • Strong Buy0
  • Buy11
  • Hold5
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$7.17$8.38$30.65$33.30
Low estimate$7.03$8.18$30.47$33.06
High estimate$7.47$8.69$30.97$33.90
No. of analysts14111515
Year-ago EPS$8.08$7.79$22.17—
Growth-11.3%+7.6%+38.2%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$74.96B$71.57B$288.43B$299.82B
Low estimate$74.00B$69.46B$285.00B$293.94B
High estimate$76.05B$76.18B$290.01B$306.02B
No. of analysts971313
Year-ago revenue$72.47B$68.49B$274.95B—
Growth+3.4%+4.5%+4.9%—
Recent analyst actions15 rating and price-target changes, latest Nov 13, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, Investing, Barrons; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for The Cigna Group. The Cigna Group has reported as a listed company since 1982. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CI12 companies · 8 funds
Compare CI with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • ALHCAlignment Healthcare, Inc.Medical - Healthcare Plans$1.6B
  • CNCCentene CorporationMedical - Healthcare Plans$37.0B
  • CVSCVS Health CorporationMedical - Healthcare Plans$113.3B
  • ELVElevance Health Inc.Medical - Healthcare Plans$96.4B
  • HUMHumana Inc.Medical - Healthcare Plans$55.4B
  • MOHMolina Healthcare, Inc.Medical - Healthcare Plans$12.2B
  • OSCROscar Health, Inc.Medical - Healthcare Plans$8.1B
  • UNHUnitedHealth Group IncorporatedMedical - Healthcare Plans$369.2B

More Medical - Healthcare Plans companies

  • UNH.NEUnitedHealth Group IncNEO
  • CLOVClover Health Investments, Corp.NASDAQ$2.6B
  • IHGPJun An Kang Group Inc.OTC$10M
  • MRAIMarpai, Inc.OTC$9M

ETFs holding The Cigna Group

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.12%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.11%
  • IVViShares Core SP 500 ETF$852.9B in assets0.12%
  • SPYState Street SPDR S&P 500 ETF Trust$818.5B in assets0.12%
  • IHFiShares US Healthcare Providers ETF$1.5B in assets4.56%
  • DUSADavis Select U.S. Equity ETF$1.3B in assets3.30%
  • FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets2.50%
  • RPVInvesco S&P 500 Pure Value ETF$1.8B in assets1.70%

Largest holders first, then the funds most concentrated in CI.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold The Cigna Group, and how their positions are changing. At a $79.09B market value, institutional positions materially move The Cigna Group's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by The Cigna Group executives and directors. Shares of The Cigna Group have traded between $239.51 and $350.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming The Cigna Group. The Cigna Group is a $79.09B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming The Cigna Group. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for The Cigna Group. Coverage tracks The Cigna Group within Medical - Healthcare Plans (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of The Cigna Group.

CI Analysis
Good
Past2
Growth5
Health3
Profit3
Value3

News

Latest Market News